Can a Blood Test Help Detect Breast Cancer Early?

Advances in science are opening up new ways to understand and detect cancer. While mammography remains the standard screening method for breast cancer, researchers are exploring whether a simple blood test could one day help identify breast cancer even before symptoms appear. This article explains the science behind blood-based detection, the benefits and limitations, and how such tests may fit into the future of breast cancer screening.

Breast Cancer Screening Today

Currently, mammograms are the gold standard for breast cancer detection. They allow radiologists to find tumors that may not be noticeable during physical exams. However, mammography does have some limitations:

• Lower accuracy in women with dense breast tissue, which is more common in younger women
• Possibility of false positives, sometimes leading to unnecessary biopsies
• Challenges in detecting certain aggressive cancer subtypes
• Limited access in rural or resource-poor settings

Because of these factors, researchers are investigating complementary methods like blood-based tests that could make screening more accessible and accurate.

Types of Blood Tests Being Researched

Scientists are studying several types of blood-based approaches:

1. Circulating Tumor Cells (CTCs):
2. Tumors sometimes shed cells into the bloodstream. Detecting these circulating tumor cells can indicate the presence of cancer. Certain blood tests have shown very high accuracy in research settings, with around 92% sensitivity and 100% specificity, including in some early-stage cancers.
3. Circulating Tumor DNA (ctDNA) and mRNA:
4. Fragments of genetic material from tumor cells can circulate in the blood. By analysing these DNA or RNA fragments, researchers can identify unique cancer-related patterns. Some studies using machine learning have achieved over 90% sensitivity in detecting breast cancer.
5. Tumor Marker Blood Tests (CA 15-3, CA 27.29):
6. These markers are already used in some cases to monitor people with breast cancer. However, they are not accurate enough for screening healthy individuals, since they can also be elevated in non-cancer conditions.

Advantages of Blood-Based Tests

If validated further, blood tests could offer important benefits:

• Convenient and non-invasive: Simple blood draws are easier than imaging or biopsies.
• Potential for earlier detection: Molecular changes may appear in the blood before tumors are visible on scans.
• Fewer false positives: High-specificity tests can reduce unnecessary follow-up procedures.
• Wider accessibility: Easier to offer in places where mammography facilities are limited.

Current Limitations

Despite promising results, blood-based breast cancer tests are not yet ready to replace traditional screening. Key challenges include:

• Lower sensitivity for very early cancers such as ductal carcinoma in situ (DCIS)
• Need for validation across large, diverse populations
• Likely need to use these tests alongside mammography or MRI, not instead of them
• Cost and availability concerns in many regions

What This Means for You

At present, blood tests are not a substitute for mammograms or clinical exams. However, they may play a supportive role in the future, particularly for women with dense breast tissue or those at higher risk.

For individuals exploring genetic risk, Orange Health offers a BRCA1 and BRCA2 profile test with convenient home sample collection and quick report delivery. Understanding your genetic profile can support early, personalised decision-making about breast and ovarian cancer risk.

Also Read: Understanding BRCA1 & 2 gene

Key Takeaway

Blood tests for breast cancer are an exciting area of research. While not yet a standard part of screening, they hold promise as complementary tools to existing methods. Staying informed about these advances and discussing your risk profile with a healthcare professional is the best way to make proactive, confident choices about your health.